Table 1. IC₅₀ Values of Tested Compounds against HMLER and HMLER^tax Cells.

compound	HMLER IC50 (μM)	HMLERtax IC50 (μM)	selectivity for HMLERtax a
1	11.20 ± 0.48	4.91 ± 0.86	2.31
2	14.58 ± 0.20	16.06 ± 4.12	0.91
3	82.80 ± 18.43	53.99 ± 2.45	1.53
salinomycin	0.49 ± 0.26	0.058 ± 0.01	8.45
abamectin	1.45 ± 0.18	0.64 ± 0.06	2.26
cisplatin	1.95 ± 0.40	2.06 ± 0.67	0.95
carboplatin	17.84 ± 0.58	18.19 ± 0.80	0.98
oxaliplatin	15.04 ± 0.41	26.95 ± 4.42	0.55
satraplatin	1.22 ± 0.06	2.87 ± 0.23	0.43
Pt(IV)-C2	39.09 ± 9.82	40.64 ± 9.91	0.96
Pt(IV)-C16	0.0254 ± 0.0016	0.1131 ± 0.0197	0.22

^aSelectivity = IC₅₀ for HMLER/IC₅₀ for HMLER^tax. The values reported are an average of five independent determinations.